In The Lancet Infectious Diseases,¹ we described a 2-year-old child from the USA who developed extensively drug-resistant pulmonary tuberculosis after a 3 month visit to India. She has been closely followed for 2 years after completing 18 months of directly observed therapy with an individualised drug regimen, including streptomycin (first 6 months), linezolid, para-aminosalicylic acid, cycloserine, and clofazimine. In the absence of clinical or microbiological markers, low-radiation exposure CT was used as a rapid biomarker to guide treatment.

中文翻译：

---

成功治愈幼儿广泛耐药的肺结核

在《柳叶刀传染病》（^1）中，我们描述了一个来自美国的2岁孩子，他在访问印度3个月后发展为广泛耐药的肺结核。在完成18个月的个性化药物治疗直接观察治疗后（包括链霉素（头6个月），利奈唑胺，对氨基水杨酸，环丝氨酸和氯法齐明），她接受了2年的密切随访。在没有临床或微生物标志物的情况下，低辐射暴露CT被用作指导治疗的快速生物标志物。